Adlai Nortye Ltd.
Palupiprant (AN0025)
Neoadj RC (+CRT)3
Date
TBD
Phase 2 readout · Date TBD estimated
What's at stake
Phase 2 trial results for Palupiprant (AN0025) in Neoadj RC (+CRT)3 are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 13h ago
“Clinical update in H2 2026”